Based on this YouTube video's total view count of 110K views and industry-standard rates, the estimated total earning is $77 - $220 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore Randomized, double blind, placebo controlled trial with 110,214 views, 3,248 likes, and 1,758 comments. Experience the impact of this video content that has captured audience attention.

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 (3rd June) BACKGROUND Whether hydroxychloroquine can prevent symptomatic infection after SARS-CoV-2 exposure is unknown. METHODS Randomized, double-blind, placebo-controlled trial United States and Canada Testing hydroxychloroquine as postexposure prophylaxis High risk, less than 6 ft for more than 10 minutes while wearing neither a face mask nor an eye shield Moderate risk, while wearing a face mask but no eye shield n = 821 asymptomatic participants (719 of 821) reported a high-risk exposure Randomly assigned, placebo or hydroxychloroquine groups within 4 days of exposure Primary outcome, incidence positive test of clinical diagnosis RESULTS Incidence of new illness Hydroxychloroquine group (49 of 414), 11.8% Placebo group (58 of 407), 14.3% P=0.35 Side effects in hydroxychloroquine group = 40.1% Side effects in control group = 16.8% No serious adverse reactions were reported. (Nausea, upset stomach, dizziness, headache) Hydroxychloroquine group Taking zinc 15% developed new disease Not taking zinc 10.8% developed new disease Placebo group Taking zinc 15.4% developed new disease Not taking zinc 14% developed new disease Relative risk with zinc use was 1.23 Hydroxychloroquine group Taking Vit C 14.3% developed new disease Not taking Vit C 10.6% developed new disease Placebo group Taking Vit C 20.8% developed new disease Not taking Vit C 11.2% developed new disease Relative risk with vitamin C use was 1.60 The Lancet (and NEJM) Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis, (May 22nd) Serious scientific questions about the validity of data ‘Expression of Concern’ https://www.thelancet.com/journals/lanpub/article/PIIS0140-6736(20)31290-3/fulltext Issued a correction regarding location of some patients Conclusions were not changed. WHO resumed its trial of hydroxychloroquine Crisis of trust Medical journals WHO Governments Scientific / medical advisors

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.